US2024000898A1PendingUtilityA1
In vivo synthesis of elastic fiber
Assignee: ALLERGAN PHARMACEUTICALS INT LTDPriority: Sep 30, 2011Filed: Jul 14, 2023Published: Jan 4, 2024
Est. expirySep 30, 2031(~5.2 yrs left)· nominal 20-yr term from priority
A61K 38/39A61K 8/64A61K 2800/91A61K 31/728A61Q 19/08A61K 8/735A61P 17/00A61P 17/02A61P 17/16A61P 39/06A61K 9/0019A61K 8/65A61K 2800/10A61K 8/73
81
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are methods of restoring elasticity in tissue using tropoelastin containing compositions.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of restoring an elastic profile of skin tissue of a human subject, the method comprising:
administering a composition comprising human tropoelastin monomers to an area of skin tissue in the human subject; and maintaining a level of the human tropoelastin monomers in the area of skin tissue for a period of time sufficient for the human tropoelastin monomers to form an elastin fiber, wherein the formed elastin fiber increases the elastic profile of the skin tissue.
2 . The method of claim 1 , wherein the human tropoelastin monomers are modified to reduce protease degradation.
3 . The method of claim 1 , wherein the step of maintaining a level of human tropoelastin monomers in the area of skin tissue comprises repeated administration of the composition comprising human tropoelastin monomers.
4 . The method of claim 1 , wherein the human tropoelastin monomers have a purity of at least 75%.
5 . The method of claim 1 , wherein the human tropoelastin monomers comprise a full length isoform of tropoelastin.
6 . The method of claim 1 further comprising pre-treating the area of skin tissue to induce cell proliferation.
7 . The method of claim 1 further comprising pre-treating the area of skin tissue to recruit cells to the area.
8 . The method of claim 1 , wherein the composition comprises a sustained release formulation of human tropoelastin monomers.
9 . The method of claim 1 , wherein the human tropoelastin monomers are released from the composition in the area of skin tissue for a period of between about 1 day to about 90 days.
10 . The method of claim 1 , wherein the human tropoelastin monomers are released from the composition about 10 days to about 180 days following administration of the composition to the area of skin tissue.
11 . The method of claim 1 , wherein the human tropoelastin monomers are present in the composition at a concentration of about 1 μg/ml to about 100 mg/ml.
12 . The method of claim 1 , wherein the composition further comprises human fibroblasts.
13 . The method of claim 3 , wherein the composition is administered to the area of skin tissue in three treatments.
14 . The method of claim 13 , wherein each of the three treatments are from about 1 week to 24 weeks apart.
15 . The method of claim 1 , wherein the composition is administered by multiple injections across the area of skin tissue.
16 . The method of claim 15 , wherein each injection comprises a volume of about 10 μl to about 100 μl.
17 . A method for forming an elastin fiber, the method comprising:
contacting an adult cell with a composition comprising tropoelastin monomers; and maintaining a level of the tropoelastin monomers in contact with the adult cell for a period of time sufficient for the adult cell to engage the tropoelastin monomers and form the elastin fiber.
18 . The method of claim 17 , wherein the composition comprises hyaluronic acid.
19 . The method of claim 17 , wherein the adult cell is a human cell.
20 . The method of claim 17 , wherein the adult cell is a fibroblast or a smooth muscle cell.Join the waitlist — get patent alerts
Track US2024000898A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.